Aethlon Medical (NASDAQ:AEMD) Stock Crosses Below Two Hundred Day Moving Average of $2.07

Aethlon Medical, Inc. (NASDAQ:AEMD) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.07 and traded as low as $1.60. Aethlon Medical shares last traded at $1.66, with a volume of 122,480 shares traded.

The company has a 50-day simple moving average of $1.93 and a two-hundred day simple moving average of $2.07. The stock has a market capitalization of $20.14 million, a price-to-earnings ratio of -0.87 and a beta of 0.66.

Aethlon Medical (NASDAQ:AEMD) last issued its earnings results on Tuesday, February 9th. The medical equipment provider reported ($0.20) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.15) by ($0.05). The business had revenue of $0.63 million during the quarter. On average, analysts anticipate that Aethlon Medical, Inc. will post -0.55 EPS for the current fiscal year.

A hedge fund recently bought a new stake in Aethlon Medical stock. Cardan Capital Partners LLC purchased a new stake in shares of Aethlon Medical, Inc. (NASDAQ:AEMD) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 15,896 shares of the medical equipment provider’s stock, valued at approximately $39,000. Cardan Capital Partners LLC owned 0.13% of Aethlon Medical as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 2.65% of the company’s stock.

About Aethlon Medical (NASDAQ:AEMD)

Aethlon Medical, Inc, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system.

Featured Article: Find a Trading Strategy That Works

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with's FREE daily email newsletter.